Skip to main content
Gilead Sciences, Inc. (ETR:GIS)
Germany flag Germany · Delayed Price · Currency is EUR
104.26
+1.28 (1.24%)
Feb 20, 2025, 5:35 PM CET

Gilead Sciences Revenue

In the year 2024, Gilead Sciences had annual revenue of $28.75B USD with 6.04% growth. Gilead Sciences had revenue of $7.57B in the quarter ending December 31, 2024, with 6.40% growth.

Revenue
$28.75B
Revenue Growth
+6.04%
P/S Ratio
n/a
Revenue / Employee
$1.60M
Employees
18,000
Market Cap
131.11B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202428.75B1.64B6.04%
Dec 31, 202327.12B-165.00M-0.60%
Dec 31, 202227.28B-24.00M-0.09%
Dec 31, 202127.31B2.62B10.60%
Dec 31, 202024.69B2.24B9.98%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Siemens Healthineers AG 22.67B
Merck KGaA 20.96B
Bayer Aktiengesellschaft 46.74B
Fresenius SE & Co. KGaA 22.81B
Sartorius Aktiengesellschaft 3.38B
Fresenius Medical Care AG 19.24B
Carl Zeiss Meditec AG 2.08B
Fielmann Group AG 2.16B
Revenue Rankings

Gilead Sciences News

More News